The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Candesartan and Hydrochlorothiazide Market Research Report 2024
Synopsis
Candesartan and Hydrochlorothiazide contains 2 medications: candesartan and hydrochlorothiazide. Candesartan belongs to a family of medications known as angiotensin II receptor blockers. Hydrochlorothiazide belongs to a family of medications known as diuretics (or "water pills"). This combination medication is used to lower high blood pressure.
The global Candesartan and Hydrochlorothiazide market was valued at US$ 303 million in 2023 and is anticipated to reach US$ 470.1 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.
North American market for Candesartan and Hydrochlorothiazide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Candesartan and Hydrochlorothiazide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Candesartan and Hydrochlorothiazide include AstraZeneca, ANI Pharmaceuticals, TEVA, Mylan, Dr. Reddy's Laboratories, Zydus Pharmaceuticals, Prinston Pharmaceutical and MACLEODS, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Candesartan and Hydrochlorothiazide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Candesartan and Hydrochlorothiazide.
Report Scope
The Candesartan and Hydrochlorothiazide market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Candesartan and Hydrochlorothiazide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Candesartan and Hydrochlorothiazide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
ANI Pharmaceuticals
TEVA
Mylan
Dr. Reddy's Laboratories
Zydus Pharmaceuticals
Prinston Pharmaceutical
MACLEODS
Segment by Type
16/12.5
32/12.5
32/25
Segment by Application
Adults
Geriatric
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Candesartan and Hydrochlorothiazide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Candesartan and Hydrochlorothiazide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Candesartan and Hydrochlorothiazide contains 2 medications: candesartan and hydrochlorothiazide. Candesartan belongs to a family of medications known as angiotensin II receptor blockers. Hydrochlorothiazide belongs to a family of medications known as diuretics (or "water pills"). This combination medication is used to lower high blood pressure.
The global Candesartan and Hydrochlorothiazide market was valued at US$ 303 million in 2023 and is anticipated to reach US$ 470.1 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.
North American market for Candesartan and Hydrochlorothiazide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Candesartan and Hydrochlorothiazide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Candesartan and Hydrochlorothiazide include AstraZeneca, ANI Pharmaceuticals, TEVA, Mylan, Dr. Reddy's Laboratories, Zydus Pharmaceuticals, Prinston Pharmaceutical and MACLEODS, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Candesartan and Hydrochlorothiazide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Candesartan and Hydrochlorothiazide.
Report Scope
The Candesartan and Hydrochlorothiazide market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Candesartan and Hydrochlorothiazide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Candesartan and Hydrochlorothiazide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
ANI Pharmaceuticals
TEVA
Mylan
Dr. Reddy's Laboratories
Zydus Pharmaceuticals
Prinston Pharmaceutical
MACLEODS
Segment by Type
16/12.5
32/12.5
32/25
Segment by Application
Adults
Geriatric
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Candesartan and Hydrochlorothiazide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Candesartan and Hydrochlorothiazide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Candesartan and Hydrochlorothiazide Market Overview
1.1 Product Overview and Scope of Candesartan and Hydrochlorothiazide
1.2 Candesartan and Hydrochlorothiazide Segment by Type
1.2.1 Global Candesartan and Hydrochlorothiazide Market Value Comparison by Type (2024-2030)
1.2.2 16/12.5
1.2.3 32/12.5
1.2.4 32/25
1.3 Candesartan and Hydrochlorothiazide Segment by Application
1.3.1 Global Candesartan and Hydrochlorothiazide Market Value by Application: (2024-2030)
1.3.2 Adults
1.3.3 Geriatric
1.4 Global Candesartan and Hydrochlorothiazide Market Size Estimates and Forecasts
1.4.1 Global Candesartan and Hydrochlorothiazide Revenue 2019-2030
1.4.2 Global Candesartan and Hydrochlorothiazide Sales 2019-2030
1.4.3 Global Candesartan and Hydrochlorothiazide Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Candesartan and Hydrochlorothiazide Market Competition by Manufacturers
2.1 Global Candesartan and Hydrochlorothiazide Sales Market Share by Manufacturers (2019-2024)
2.2 Global Candesartan and Hydrochlorothiazide Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Candesartan and Hydrochlorothiazide Average Price by Manufacturers (2019-2024)
2.4 Global Candesartan and Hydrochlorothiazide Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Candesartan and Hydrochlorothiazide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Candesartan and Hydrochlorothiazide, Product Type & Application
2.7 Candesartan and Hydrochlorothiazide Market Competitive Situation and Trends
2.7.1 Candesartan and Hydrochlorothiazide Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Candesartan and Hydrochlorothiazide Players Market Share by Revenue
2.7.3 Global Candesartan and Hydrochlorothiazide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Candesartan and Hydrochlorothiazide Retrospective Market Scenario by Region
3.1 Global Candesartan and Hydrochlorothiazide Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Candesartan and Hydrochlorothiazide Global Candesartan and Hydrochlorothiazide Sales by Region: 2019-2030
3.2.1 Global Candesartan and Hydrochlorothiazide Sales by Region: 2019-2024
3.2.2 Global Candesartan and Hydrochlorothiazide Sales by Region: 2025-2030
3.3 Global Candesartan and Hydrochlorothiazide Global Candesartan and Hydrochlorothiazide Revenue by Region: 2019-2030
3.3.1 Global Candesartan and Hydrochlorothiazide Revenue by Region: 2019-2024
3.3.2 Global Candesartan and Hydrochlorothiazide Revenue by Region: 2025-2030
3.4 North America Candesartan and Hydrochlorothiazide Market Facts & Figures by Country
3.4.1 North America Candesartan and Hydrochlorothiazide Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Candesartan and Hydrochlorothiazide Sales by Country (2019-2030)
3.4.3 North America Candesartan and Hydrochlorothiazide Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Candesartan and Hydrochlorothiazide Market Facts & Figures by Country
3.5.1 Europe Candesartan and Hydrochlorothiazide Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Candesartan and Hydrochlorothiazide Sales by Country (2019-2030)
3.5.3 Europe Candesartan and Hydrochlorothiazide Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Candesartan and Hydrochlorothiazide Market Facts & Figures by Country
3.6.1 Asia Pacific Candesartan and Hydrochlorothiazide Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Candesartan and Hydrochlorothiazide Sales by Country (2019-2030)
3.6.3 Asia Pacific Candesartan and Hydrochlorothiazide Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Candesartan and Hydrochlorothiazide Market Facts & Figures by Country
3.7.1 Latin America Candesartan and Hydrochlorothiazide Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Candesartan and Hydrochlorothiazide Sales by Country (2019-2030)
3.7.3 Latin America Candesartan and Hydrochlorothiazide Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Candesartan and Hydrochlorothiazide Market Facts & Figures by Country
3.8.1 Middle East and Africa Candesartan and Hydrochlorothiazide Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Candesartan and Hydrochlorothiazide Sales by Country (2019-2030)
3.8.3 Middle East and Africa Candesartan and Hydrochlorothiazide Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Candesartan and Hydrochlorothiazide Sales by Type (2019-2030)
4.1.1 Global Candesartan and Hydrochlorothiazide Sales by Type (2019-2024)
4.1.2 Global Candesartan and Hydrochlorothiazide Sales by Type (2025-2030)
4.1.3 Global Candesartan and Hydrochlorothiazide Sales Market Share by Type (2019-2030)
4.2 Global Candesartan and Hydrochlorothiazide Revenue by Type (2019-2030)
4.2.1 Global Candesartan and Hydrochlorothiazide Revenue by Type (2019-2024)
4.2.2 Global Candesartan and Hydrochlorothiazide Revenue by Type (2025-2030)
4.2.3 Global Candesartan and Hydrochlorothiazide Revenue Market Share by Type (2019-2030)
4.3 Global Candesartan and Hydrochlorothiazide Price by Type (2019-2030)
5 Segment by Application
5.1 Global Candesartan and Hydrochlorothiazide Sales by Application (2019-2030)
5.1.1 Global Candesartan and Hydrochlorothiazide Sales by Application (2019-2024)
5.1.2 Global Candesartan and Hydrochlorothiazide Sales by Application (2025-2030)
5.1.3 Global Candesartan and Hydrochlorothiazide Sales Market Share by Application (2019-2030)
5.2 Global Candesartan and Hydrochlorothiazide Revenue by Application (2019-2030)
5.2.1 Global Candesartan and Hydrochlorothiazide Revenue by Application (2019-2024)
5.2.2 Global Candesartan and Hydrochlorothiazide Revenue by Application (2025-2030)
5.2.3 Global Candesartan and Hydrochlorothiazide Revenue Market Share by Application (2019-2030)
5.3 Global Candesartan and Hydrochlorothiazide Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AstraZeneca Candesartan and Hydrochlorothiazide Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 ANI Pharmaceuticals
6.2.1 ANI Pharmaceuticals Corporation Information
6.2.2 ANI Pharmaceuticals Description and Business Overview
6.2.3 ANI Pharmaceuticals Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.2.4 ANI Pharmaceuticals Candesartan and Hydrochlorothiazide Product Portfolio
6.2.5 ANI Pharmaceuticals Recent Developments/Updates
6.3 TEVA
6.3.1 TEVA Corporation Information
6.3.2 TEVA Description and Business Overview
6.3.3 TEVA Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.3.4 TEVA Candesartan and Hydrochlorothiazide Product Portfolio
6.3.5 TEVA Recent Developments/Updates
6.4 Mylan
6.4.1 Mylan Corporation Information
6.4.2 Mylan Description and Business Overview
6.4.3 Mylan Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Mylan Candesartan and Hydrochlorothiazide Product Portfolio
6.4.5 Mylan Recent Developments/Updates
6.5 Dr. Reddy's Laboratories
6.5.1 Dr. Reddy's Laboratories Corporation Information
6.5.2 Dr. Reddy's Laboratories Description and Business Overview
6.5.3 Dr. Reddy's Laboratories Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Dr. Reddy's Laboratories Candesartan and Hydrochlorothiazide Product Portfolio
6.5.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.6 Zydus Pharmaceuticals
6.6.1 Zydus Pharmaceuticals Corporation Information
6.6.2 Zydus Pharmaceuticals Description and Business Overview
6.6.3 Zydus Pharmaceuticals Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Zydus Pharmaceuticals Candesartan and Hydrochlorothiazide Product Portfolio
6.6.5 Zydus Pharmaceuticals Recent Developments/Updates
6.7 Prinston Pharmaceutical
6.6.1 Prinston Pharmaceutical Corporation Information
6.6.2 Prinston Pharmaceutical Description and Business Overview
6.6.3 Prinston Pharmaceutical Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Prinston Pharmaceutical Candesartan and Hydrochlorothiazide Product Portfolio
6.7.5 Prinston Pharmaceutical Recent Developments/Updates
6.8 MACLEODS
6.8.1 MACLEODS Corporation Information
6.8.2 MACLEODS Description and Business Overview
6.8.3 MACLEODS Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2019-2024)
6.8.4 MACLEODS Candesartan and Hydrochlorothiazide Product Portfolio
6.8.5 MACLEODS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Candesartan and Hydrochlorothiazide Industry Chain Analysis
7.2 Candesartan and Hydrochlorothiazide Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Candesartan and Hydrochlorothiazide Production Mode & Process
7.4 Candesartan and Hydrochlorothiazide Sales and Marketing
7.4.1 Candesartan and Hydrochlorothiazide Sales Channels
7.4.2 Candesartan and Hydrochlorothiazide Distributors
7.5 Candesartan and Hydrochlorothiazide Customers
8 Candesartan and Hydrochlorothiazide Market Dynamics
8.1 Candesartan and Hydrochlorothiazide Industry Trends
8.2 Candesartan and Hydrochlorothiazide Market Drivers
8.3 Candesartan and Hydrochlorothiazide Market Challenges
8.4 Candesartan and Hydrochlorothiazide Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
